Provider page
CoreAge Rx — Bounce Back ↗
Starting $64.99/month, advertised Copper Peptide 2%, consultation and compounding claims. Complete base, precise peptide identity, supply and final terms not independently verified.
Accessed 2026-09-25
THE SOURCE REGISTER
Keep the source
with the statement.
Primary product pages establish what a company says. Published studies and authoritative guidance answer different questions. All pages were accessed September 25, 2026; that is not a claim that their content was published that day.
Manufacturer page
The Ordinary — Multi-Peptide + Copper Peptides 1% Serum ↗
US 30 mL page: temporary $28.80 offer, reduced from $32; stock-notification option. Ingredient declaration, compatibility directions and formula-update notice inspected.
Accessed 2026-09-25
Manufacturer page
NIOD — Copper Amino Isolate Serum 3 1:1 ↗
GHK-Cu/GHK descriptions, ingredient declaration and manufacturer study footnotes inspected. Full study reports were not independently appraised. Size choices are not interchangeable. Direct size selection confirmed $62 for 15 mL and $93 for 30 mL.
Accessed 2026-09-25
Manufacturer page
Biossance — Squalane + Copper Peptide Rapid Plumping Serum ↗
50 mL full size $69 and marked in stock. Full public ingredient list and study footnotes inspected; copper-peptide concentration not established. No checkout or wear test.
Accessed 2026-09-25
Published randomized study
Topical copper tripeptide after CO₂ laser resurfacing (2006) ↗
Abstract reviewed: 13 completers in a post-laser setting. Objective between-group differences were not significant; patient-reported satisfaction favored GHK-Cu. Not a trial of the current reviewed products.
Accessed 2026-09-25
Regulatory guidance
FDA — Risks of compounded drugs ↗
Explains lack of FDA approval and premarket review for compounded drugs. General guidance, not a pharmacy inspection report.
Accessed 2026-09-25
Regulatory guidance
FDA — Cosmetics Labeling Guide ↗
General ingredient-order rules, including the 1% or less exception and separate color-additive provisions. Not a determination about any particular product.
Accessed 2026-09-25
Regulatory guidance
FDA — Cosmetic, drug, or both? ↗
Explains intended use, product claims and the distinction between cosmetics and drugs. No separate legal category for cosmeceuticals.
Accessed 2026-09-25
Dermatology guidance
AAD — Testing skincare products at home ↗
General cosmetic home-testing and reaction guidance; medical patch testing is distinct. Page states last updated August 10, 2021; access date is not a new publication date.
Accessed 2026-09-25
Dermatology guidance
AAD — Wrinkle remedies ↗
Sun protection, moisturizer, product directions and limiting irritation. Does not endorse a copper-peptide brand.
Accessed 2026-09-25
Dermatology guidance
AAD — Choosing a moisturizer ↗
General distinctions between gels, lotions, creams and ointments, plus dryness and sun-protection context. Not a sensory test of reviewed products.
Accessed 2026-09-25
Dermatology guidance
AAD — Skin care during menopause ↗
Context for dryness and changing skin; new or concerning lesions require appropriate assessment. Not evidence that copper peptides reverse hormonal changes.
Accessed 2026-09-25
Product prices, availability, ingredients, and directions can change. Our editorial method explains the limits of this public-source review.